IDH1 Mutation as a Predictor of Glioma Progression

被引:0
|
作者
Knobbe, C.
Nesrin, S.
von Deimling, A.
Mak, T. W.
Guha, A.
Croul, S. E.
机构
[1] Princess Margaret Hosp, Campbell Family Inst Breast Canc Res, Toronto, ON M4X 1K9, Canada
[2] Univ Toronto, Hosp Sick Children, Res Inst, Arthur & Sonia Labatts Brain Tumor Ctr, Toronto, ON M5G 1X8, Canada
[3] Univ Toronto, Div Neurosurg, Toronto, ON M5S 1A1, Canada
[4] Univ Hlth Network Pathol, Toronto, ON, Canada
[5] Univ Heidelberg, Inst Pathol, D-6900 Heidelberg, Germany
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1623
引用
收藏
页码:382A / 382A
页数:1
相关论文
共 50 条
  • [21] New Developments in the Pathogenesis and Therapeutic Targeting of the IDH1 Mutation in Glioma
    Dimitrov, Lilia
    Hong, Christopher S.
    Yang, Chunzhang
    Zhuang, Zhengping
    Heiss, John D.
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2015, 12 (03): : 201 - 213
  • [22] Pattern of failure in anaplastic glioma patients with an IDH1/2 mutation
    Back, M.
    Jayamanne, D.
    Brazier, D.
    Newey, A.
    Bailey, D.
    Schembri, G.
    Hsiao, E.
    Khasraw, M.
    Wong, M.
    Kastelan, M.
    Brown, C.
    Wheeler, H.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (01) : 31 - 39
  • [23] IDH1 MUTATION REGULATES MYELOID CELLS MEDIATED IMMUNOSUPPRESSION IN GLIOMA
    Alghamri, Mahmoud S.
    Kamran, Neha
    Nunez, Felipe J.
    Lowenstein, Pedro R.
    Castro, Maria G.
    NEURO-ONCOLOGY, 2017, 19 : 125 - 126
  • [24] MUTATION OF ISOCITRATE DEHYDROGENASE (IDH1) IN BRAIN TUMORS AS A PREDICTOR FOR SURVIVAL
    Pesce, G.
    Bleeker, F. E.
    Martin, V
    Mauri, S.
    Lamba, S.
    Boscherini, D.
    Renella, R. R.
    Mazzucchelli, L.
    Bardelli, A.
    Frattin, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2009, 185 (09) : 634 - 634
  • [25] IDH1 Overexpression Induced Chemotherapy Resistance and IDH1 Mutation Enhanced Chemotherapy Sensitivity in Glioma Cells in Vitro and in Vivo
    Wang, Ju-Bo
    Dong, Dan-Feng
    Wang, Mao-De
    Gao, Ke
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (01) : 427 - 432
  • [26] Pattern of failure in anaplastic glioma patients with an IDH1/2 mutation; [Rezidivmuster bei Patienten mit anaplastischem Glioma mit einer IDH1/2-Mutation]
    Back M.
    Jayamanne D.
    Brazier D.
    Newey A.
    Bailey D.
    Schembri G.
    Hsiao E.
    Khasraw M.
    Wong M.
    Kastelan M.
    Brown C.
    Wheeler H.
    Strahlentherapie und Onkologie, 2020, 196 (1) : 31 - 39
  • [27] The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen
    Malta, Tathiane M.
    Sabedot, Thais S.
    Morosini, Natalia S.
    Datta, Indrani
    Garofano, Luciano
    Vallentgoed, Wies
    Varn, Frederick S.
    Aldape, Kenneth
    D'Angelo, Fulvio
    Bakas, Spyridon
    Barnholtz-Sloan, Jill S.
    Gan, Hui K.
    Hasanain, Mohammad
    Hau, Ann-Christin
    Johnson, Kevin C.
    Cazacu, Simona
    deCarvalho, Ana C.
    Khasraw, Mustafa
    Kocakavuk, Emre
    Kouwenhoven, Mathilde C. M.
    Migliozzi, Simona
    Niclou, Simone P.
    Niers, Johanna M.
    Ormond, D. Ryan
    Paek, Sun Ha
    Reifenberger, Guido
    Sillevis Smitt, Peter A.
    Smits, Marion
    Stead, Lucy F.
    van den Bent, Martin J.
    Van Meir, Erwin G.
    Walenkamp, Annemiek
    Weiss, Tobias
    Weller, Michael
    Westerman, Bart A.
    Ylstra, Bauke
    Wesseling, Pieter
    Lasorella, Anna
    French, Pim J.
    Poisson, Laila M.
    Woehrer, Adelheid
    Verhaak, Roel G. W.
    Iavarone, Antonio
    Noushmehr, Houtan
    CANCER RESEARCH, 2024, 84 (05) : 741 - 756
  • [28] IDH1 mutation impairs antiviral response and potentiates oncolytic virotherapy in glioma
    Chen, Xueqin
    Liu, Jun
    Li, Yuqin
    Zeng, Yuequan
    Wang, Fang
    Cheng, Zexiong
    Duan, Hao
    Pan, Guopeng
    Yang, Shangqi
    Chen, Yuling
    Li, Qing
    Shen, Xi
    Li, Ying
    Qin, Zixi
    Chen, Jiahong
    Huang, Youwei
    Wang, Xiangyu
    Lu, Yuli
    Shu, Minfeng
    Zhang, Yubo
    Wang, Guocai
    Li, Kai
    Lin, Xi
    Xing, Fan
    Zhang, Haipeng
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [29] Quantitative metabolome analysis profiles activation of glutaminolysis in glioma with IDH1 mutation
    Ohka, Fumiharu
    Ito, Maki
    Ranjit, Melissa
    Senga, Takeshi
    Motomura, Ayako
    Motomura, Kazuya
    Saito, Kaori
    Kato, Keiko
    Kato, Yukinari
    Wakabayashi, Toshihiko
    Soga, Tomoyoshi
    Natsume, Atsushi
    TUMOR BIOLOGY, 2014, 35 (06) : 5911 - 5920
  • [30] IDH1 mutation in Balinese glioma patients and its relationship with clinicopathological parameters
    Sriwidyani, Ni Putu
    Wahyuniari, Ida Ayu Ika
    Saputra, Herman
    Arijana, I. Gusti Kamasan Nyoman
    BALI MEDICAL JOURNAL, 2020, 9 (03) : 820 - 823